PRNewswire | May 29, 2023
Tomorrow Health, an innovator in home-based care, announced that it has closed its first-party home medical equipment (HME) supply business to remove barriers and unlock new opportunities for its network of home-based care providers. Tomorrow Health serves as a partner for home-based care needs to leading suppliers, including AdaptHealth, Apria, Home Care Delivered, Lincare, and Rotech Healthcare, providing each with holistic technology solutions that streamlines end-to-end workflows and enables unparalleled operational efficiency at scale.
Tomorrow Health's vision has always been to restore the home as the primary point of care. Initially, it sought to achieve this vision by operating its own home medical equipment (HME) supplier business. A more powerful opportunity to shift care to the home quickly revealed itself: the transformation of the end-to-end process of how HME is ordered, processed, and delivered to patients at scale.
Tomorrow Health evolved, building a market-leading connective technology and service layer that coordinates care seamlessly across payers, referring providers, patients and home-based care suppliers. The company's unique approach, built on its prior learnings as an HME supplier business, has delivered technology that supercharges home-based care provider growth via high-quality, cost-effective care. With its technology seeing rapid adoption and impact, Tomorrow Health has formally closed its HME supplier business.
Tomorrow Health's decision to concentrate its focus on technology for supplier partners comes as the broader healthcare ecosystem shifts its strategic priorities and seeks greater support in enabling the delivery and reimbursement of quality home-based care.
Nearly 91% of health plans have recently indicated plans to move more care to the home. HME suppliers are facing a critical challenge: meeting that demand in an operationally efficient manner. A recent HME delivery cost survey found that new personal protective equipment expenses, plus longer round trips with associated fuel and labor expenses, have increased overall delivery costs by 30% or more for most suppliers.
"HME suppliers are a critical lever to shift care to the home, which is often overlooked by payors," Vijay Kedar, CEO and Co-Founder, Tomorrow Health." Tomorrow Health's technology and unique position with payors enables change end-to-end, supporting everything from prescription to reimbursement while arming suppliers with valuable insights that can drive business growth and ensure positive experiences for every single stakeholder."
"Tomorrow Health is not only focused on delivering high-quality, innovative technology to suppliers in need of operational efficiencies, but they're also connecting with suppliers to understand what is and isn't working for them," said Tom Ryan, President and CEO, American Association for Homecare (AAHomecare), an advocacy organization for home-care providers and DME and HME companies. "By actively seeking out and listening to feedback from the supplier community, Tomorrow Health has been able to build a solution that drives definitively better outcomes for everyone."
Many suppliers today receive HME orders from one-size-fits-all digital solutions that don't meet payor requirements or specific clinical needs. Tomorrow Health delivers an intuitive, precise digital order to suppliers within its platform, prioritizing urgent, same-day orders and queuing other provider orders as they come in, in compliance with payor requirements.
Tomorrow Health has reduced supplier operating expenses by up to 24%. All necessary documentation is included in the order, with 87% of orders having enough information to be immediately serviceable. The supplier also has the ability to communicate with all necessary parties, including payers and providers, about the order through the platform.
"Our partnership with Tomorrow Health enables us to automate and dramatically scale Home Care Delivered's best-in-class customer onboarding process, while simultaneously allowing us to drive the clinical, quality, and financial outcomes that are needed by patients, their healthcare providers, and payers," said Lowell Price, Senior Vice President of Business Development and Chief Growth Officer of Home Care Delivered. "While there are other e-platforms in the market today that we support, none are more strategically aligned to us in both commitment and capability to delivering value-based care in DME than Tomorrow Health. We couldn't be more excited about our partnership."
About Tomorrow Health
Tomorrow Health builds technology that improves the way home-based care is ordered, delivered, and paid for. Today, the home-based care ecosystem is fragmented, confusing, and expensive, costing the healthcare system billions of dollars annually. Tomorrow Health manages and improves every step of the process, using technology-driven matching and considering quality, specialization, insurance coverage, and geography to pair patients with appropriate suppliers of more than 40,000 products and services, leading to improved patient health results and lowered costs. Tomorrow Health partners with more than 125 leading health plans and health systems nationwide, including Pennsylvania's Geisinger Health Plan, and is backed by Andreessen Horowitz, BOND, Obvious Ventures, BoxGroup, Rainfall Ventures, and Sound Ventures.
PRNewswire | May 30, 2023
Viva Vita and Waya Health are joining forces to simplify the integration of virtual reality (VR) technology for healthcare providers. Through this collaboration, patients, including residents in senior living communities, will gain access to advanced VR experiences that will revolutionize their daily healthcare journey.
The healthcare sector's growing interest in VR poses challenges due to fragmented solutions. Viva Vita and Waya Health's partnership offers a unified offering on a single VR headset, facilitating easier integration with existing healthcare systems and workflows and reducing the complexity and costs associated with implementing VR technology.
"This collaboration - or 'Coalition' - we're forming could not come at a better time," said Carleigh Berryman, CEO of Viva Vita."Healthcare providers can now bundle the Waya Health and Viva Vita product suite, saving time, effort, resources, all while gaining access to a comprehensive suite of VR solutions that cater to their specific needs."
By seamlessly integrating VR solutions across health systems, senior living brands, rehabilitation systems, and more, Viva Vita and Waya Health aspire to drive industry-wide transformation.
"This partnership brings us closer to our mission of enabling immersive patient experiences, empowering providers with new tools and insights, and optimizing healthcare systems for improved efficiency and effectiveness. ," said Joe Morgan MD, President at Waya Health. "Leveraging the proven technologies of Waya Health and Viva Vita, along with our combined know-how for success at scale, we are in a position to disrupt healthcare in ways that were previously unimaginable."
About Waya Health
Waya Health was founded by clinicians who are leveraging technology to improve the lives of patients, colleagues, and what is possible in healthcare. As a healthcare company first, we are committed to creating better patient outcomes, whether that is less pain, reduced anxiety, a speedier recovery or reducing the need for drugs. The Waya platform is a unified virtual reality platform that allows this technology to be deployed in the most sensible, cost-effective, and versatile way. We constantly strive to add new capabilities as the potential of this technology is discovered, tested and proven. Our values are in line with the patients, doctors, and the medical support staff we empower with our leading-edge technological tools. We are clinicians harnessing the power of technology.
Businesswire | June 01, 2023
Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, announces the launch of its next-generation market insights technology platform to support rapid insights and data collection in the healthcare and life science industries. The advanced platform is fueled by the company’s ongoing investments in its core technologies, propelled by machine learning (ML) and artificial intelligence (AI).
With a modern enterprise data architecture, built from best-in-class technologies, Apollo’s next-generation platform provides customers with advanced capabilities to support their progressive insight and data needs. The platform uses ML sampling intelligence to reach global healthcare professional (HCP) panelists with higher efficiency, offering the right research opportunities to the right HCP stakeholders, at the right place and time. This new, advanced capability fosters a seamless cycle of targeted interaction and ongoing engagement that enables greater speed-to-insight and higher quality data. For HCPs, Apollo’s enhanced routing capabilities mean they receive more relevant and matched opportunities to share their expertise and amplify their voice.
Capabilities currently rolling out in beta include
natural language processing (NLP) advancements in open text analysis for tagging, coding, ML-enhanced adverse event (AE) detection, and reporting.
ML-based honoraria optimization for panel engagement.
dynamic profiling and validation.
In the second half of 2023, these foundational capabilities will support further ML and AI advancements focused on sentiment analysis for free text, survey automation, and expanded global capabilities.
“Apollo has been on a multi-year, multimillion-dollar journey building towards this moment when our investments in data and technology would allow us to take advantage of advances in machine learning and data science applications to provide our clients with an unmatched service experience,” said Daniel S. Fitzgerald, president and CEO of Apollo Intelligence. “Life science companies will be able to see the immediate impact in speed and data quality as we leverage machine learning to intelligently sample our HCP communities for data collection. These advances are just the beginning for Apollo as we continue our innovative journey and extend our robust roadmap to deliver higher quality data, speed-to-insight, and advanced analytics and data visualization for our clients.”
Apollo has made sizable investments in its platform since 2019 in anticipation of this launch. Its relationship with Frazier Healthcare Partners, in June 2022, has accelerated investment in these areas, with Frazier and Apollo sharing a vision for technological innovation within the healthcare data and insights market. The Frazier Data and AI Center of Excellence has been an instrumental partner in rapidly advancing these modern elements and realizing Apollo’s technology vision.
Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners.